APYX Apyx Medical
- 1.410
- -0.010-0.70%
Apyx Medical News
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced that financial results for the
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion Users' Summit
Shaping the Future of Aesthetic Treatments with Advanced Medical Technology Apyx Medical Corporation (NASDAQ:APYX) (the "Apyx Medical"; "Company"), the manufacturer of a proprietary helium plasma and
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersJaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), LifeMD (LFMD) and Apyx Medical (APYX)
Craig-Hallum Releases a Buy Rating on Apyx Medical (APYX)
Express News | Stavros G. Vizirgianakis Reported 5.04% Stake In Apyx Medical As Of March 25 In 13D Filing
Apyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Cutting Their Estimates
Apyx Medical Corporation (NASDAQ:APYX) Q4 2023 Earnings Call Transcript
Lake Street Reaffirms Their Buy Rating on Apyx Medical (APYX)
Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)
Further Weakness as Apyx Medical (NASDAQ:APYX) Drops 22% This Week, Taking Three-year Losses to 87%
Apyx Medical (APYX) Receives a Hold From JMP Securities
Earnings Call Summary | Apyx Medical(APYX.US) Q4 2023 Earnings Conference
The following is a summary of the Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript:Financial Performance:Apyx Medical Corporation reported a 16% year-over-year increase in total revenu
Gold Gains 1%; Micron Posts Upbeat Results
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.84% to 39,844.27 while the NASDAQ rose 0.61% to 16,469.28. The S&
PHIO and MGRM Among Healthcare Movers
Analysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Apyx Medical (APYX)
Express News | Apyx Medical Shares Are Trading Lower Following Soft FY24 Guidance
Apyx Medical Reports Mixed Q4 Results; Initiates FY24 Outlook
Apyx Medical Expects FY2024 Sales Of $49.7M-$52.9M Versus Consensus Of $60.18M, With Net Loss Of $(26.5)M-$(24.3)M
Total revenue guidance assumes: Advanced Energy revenue in the range of $41.6 million to $44.6 million, representing a decrease of approximately 4% to growth of approximately 3% year-over-year, compar
Apyx Medical Q4 GAAP EPS $(0.28) May Not Be Comparable To $(0.18) Estimate, Sales $14.66M Miss $14.85M Estimate
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.18) by 55.56 percent. This is a 64.71 percent decrease over losses of $(0.1
Analysis
Price Target
No Data
